Cardiol Therapeutics Inc. balance sheet

At the end of fiscal 2021, Cardiol Therapeutics Inc. had total assets of $68.8m, total liabilities of $9.1m and shareholders' equity of $59.7m. It held $65.7m in cash against $0 of debt: net cash of $65.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cardiol Therapeutics Inc.: balance sheet, annual
Fiscal year	2021Dec 2021
Cash and equivalents	66
Total current assets	68
Total assets	69
Total current liabilities	9
Total debt	0
Total liabilities	9
Shareholders' equity	60
Net debt (negative = net cash)	−66

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Cardiol Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardiol Therapeutics Inc.